Synteni Overview

  • Founded
  • 1994


  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $72.9M

Synteni General Information


Developer of genomics microarrays technology. The company has developed Gene Expression Microarray (GEM) which consists of up to ten thousand genes densely arrayed on a glass surface. GEM arrays are capable of analyzing thousands of genes in a single experiment by probing with fluorescently tagged DNA or RNA from a biological sample.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • Palo Alto, CA 94306
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Synteni Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 06-Jan-1998 $72.9M 000.00 Completed Generating Revenue
1. Early Stage VC Completed Startup
To view Synteni’s complete valuation and funding history, request access »

Synteni Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Kleiner Perkins Venture Capital Minority 000 0000 000000 0
Shalon Ventures Venture Capital Minority 000 0000 000000 0
To view Synteni’s complete investors history, request access »